Register
EXTEND trial shows feasibility of thrombolysis beyond 4.5-hour window in selected patients |
Clinical News
eMediNexus Coverage from: 
EXTEND trial shows feasibility of thrombolysis beyond 4.5-hour window in selected patients
eMediNexus,  12 February 2019
remove_red_eye 584 Views
#Cardiology #Emergency Medicine #Neurology #Pharmacist

0 Read Comments                

Thrombolysis for acute ischemic stroke is currently restricted to 4.5 hours from onset. But, the results of the EXTEND trial presented at the American Heart Association International Stroke Conference (ISC) has shown that ischemic stroke patients with salvageable brain tissue presenting 4.5-9 hours from onset or with WUS who received alteplase achieved better functional outcomes, reperfusion and early neurological improvement. Mortality was comparable despite num
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!